| Fasudil and DETA NONOate, loaded in a peptide-modified liposomal carrier, slow PAH progression upon pulmonary delivery J Rashid, K Nahar, S Raut, A Keshavarz, F Ahsan Molecular pharmaceutics 15 (5), 1755-1765, 2018 | 37 | 2018 |
| Oxygen-glucose deprivation/reoxygenation-induced barrier disruption at the human blood–brain barrier is partially mediated through the HIF-1 pathway S Page, S Raut, A Al-Ahmad Neuromolecular medicine 21 (4), 414-431, 2019 | 33 | 2019 |
| Understanding the brain uptake and permeability of small molecules through the BBB: A technical overview EA Chowdhury, B Noorani, F Alqahtani, A Bhalerao, S Raut, ... Journal of Cerebral Blood Flow & Metabolism 41 (8), 1797-1820, 2021 | 32 | 2021 |
| Presence of a mutation in PSEN1 or PSEN2 gene is associated with an impaired brain endothelial cell phenotype in vitro S Raut, R Patel, AJ Al-Ahmad Fluids and Barriers of the CNS 18, 1-16, 2021 | 27 | 2021 |
| A quasi-physiological microfluidic blood-brain barrier model for brain permeability studies B Noorani, A Bhalerao, S Raut, E Nozohouri, U Bickel, L Cucullo Pharmaceutics 13 (9), 1474, 2021 | 18 | 2021 |
| An iPSC-derived neuron model of CLN3 disease facilitates small molecule phenotypic screening N Kinarivala, A Morsy, R Patel, AV Carmona, MS Sajib, S Raut, ... ACS pharmacology & translational science 3 (5), 931-947, 2020 | 16 | 2020 |
| Neurological diseases at the blood-brain barrier: Stemming new scientific paradigms using patient-derived induced pluripotent cells S Page, R Patel, S Raut, A Al-Ahmad Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1866 (4), 165358, 2020 | 16 | 2020 |
| Molecular mechanisms of multi-organ failure in COVID-19 and potential of stem cell therapy A Bhalerao, S Raut, B Noorani, S Mancuso, L Cucullo Cells 10 (11), 2878, 2021 | 13 | 2021 |
| Identification and characterization of stressed degradation products of rabeprazole using LC-ESI/MS/MS and 1 H-NMR experiments: in vitro toxicity evaluation of major … MM Bhandi, RM Borkar, G Shankar, S Raut, N Nagesh, R Srinivas RSC advances 6 (13), 10719-10735, 2016 | 13 | 2016 |
| Hypometabolism, Alzheimer’s Disease, and Possible Therapeutic Targets: An Overview S Raut, A Bhalerao, M Powers, M Gonzalez, S Mancuso, L Cucullo Cells 12 (16), 2019, 2023 | 7 | 2023 |
| In vitro models of the blood–brain barrier S Raut, A Bhalerao, B Noorani, L Cucullo The Blood-Brain Barrier: Methods and Protocols, 25-49, 2022 | 6 | 2022 |
| Abeta peptides disrupt the barrier integrity and glucose metabolism of human induced pluripotent stem cell-derived brain microvascular endothelial cells S Raut, R Patel, I Pervaiz, AJ Al-Ahmad Neurotoxicology 89, 110-120, 2022 | 6 | 2022 |
| Assessment of injectable and cohesive nanohydroxyapatite composites for biological functions SSB Komakula, S Raut, NP Verma, TA Raj, MJ Kumar, A Sinha, S Singh Progress in Biomaterials 4, 31-38, 2015 | 5 | 2015 |
| Advanced Microfluidic Vascularized Tissues as Platform for the Study of Human Diseases and Drug Development B Noorani, L Cucullo, Y Ahn, H Kadry, A Bhalerao, S Raut, E Nozohouri, ... Current Neuropharmacology 21 (3), 599, 2023 | 1 | 2023 |
| Induced pluripotent stem cells derived brain endothelial cells from patients suffering from familial form of Alzheimer’s disease display impaired barrier function and cell … S Raut, R Patel, A Al-Ahmad | 1 | 2020 |
| Generating Kidney Organoids from Human Induced Pluripotent Stem Cells-Potential for Treating Kidney Disease S Raut Biomedical Journal of Scientific & Technical Research 53 (5), 45104-45110, 2023 | | 2023 |
| Letters in Applied Na S Raut, S Singh | | |
